Genentech trastuzumab emtansine shows efficacy in Phase II trial
The study compared trastuzumab emtansine to standard treatment with Herceptin (trastuzumab) plus docetaxel chemotherapy. The results of the trial suggested that the patients who were given trastuzumab emtansine
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.